BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 37479716)

  • 1. Stem cell-derived intestinal organoids: a novel modality for IBD.
    Tian CM; Yang MF; Xu HM; Zhu MZ; Yue NN; Zhang Y; Shi RY; Yao J; Wang LS; Liang YJ; Li DF
    Cell Death Discov; 2023 Jul; 9(1):255. PubMed ID: 37479716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-derived organoids for therapy personalization in inflammatory bowel diseases.
    Lucafò M; Muzzo A; Marcuzzi M; Giorio L; Decorti G; Stocco G
    World J Gastroenterol; 2022 Jun; 28(24):2636-2653. PubMed ID: 35979165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges and opportunities in inflammatory bowel disease: from current therapeutic strategies to organoid-based models.
    Kong L; Chen S; Huang S; Zheng A; Gao S; Ye J; Hua C
    Inflamm Res; 2024 Apr; 73(4):541-562. PubMed ID: 38345635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing the Biology of Canine Intestinal Organoids to Heighten Understanding of Inflammatory Bowel Disease Pathogenesis and Accelerate Drug Discovery: A One Health Approach.
    Kopper JJ; Iennarella-Servantez C; Jergens AE; Sahoo DK; Guillot E; Bourgois-Mochel A; Martinez MN; Allenspach K; Mochel JP
    Front Toxicol; 2021; 3():773953. PubMed ID: 35295115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fully automated high-throughput workflow for 3D-based chemical screening in human midbrain organoids.
    Renner H; Grabos M; Becker KJ; Kagermeier TE; Wu J; Otto M; Peischard S; Zeuschner D; TsyTsyura Y; Disse P; Klingauf J; Leidel SA; Seebohm G; Schöler HR; Bruder JM
    Elife; 2020 Nov; 9():. PubMed ID: 33138918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organoid Medicine for Inflammatory Bowel Disease.
    Wakisaka Y; Sugimoto S; Sato T
    Stem Cells; 2022 Mar; 40(2):123-132. PubMed ID: 35258629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Use of Human Stem Cell-Derived Intestinal Organoids to Study Inflammatory Bowel Diseases.
    Dotti I; Salas A
    Inflamm Bowel Dis; 2018 Nov; 24(12):2501-2509. PubMed ID: 30169820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic scaffolds for 3D cell cultures and organoids: applications in regenerative medicine.
    Marchini A; Gelain F
    Crit Rev Biotechnol; 2022 May; 42(3):468-486. PubMed ID: 34187261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Merits and challenges of iPSC-derived organoids for clinical applications.
    Xu Z; Yang J; Xin X; Liu C; Li L; Mei X; Li M
    Front Cell Dev Biol; 2023; 11():1188905. PubMed ID: 37305682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organoids: a novel modality in disease modeling.
    Heydari Z; Moeinvaziri F; Agarwal T; Pooyan P; Shpichka A; Maiti TK; Timashev P; Baharvand H; Vosough M
    Biodes Manuf; 2021; 4(4):689-716. PubMed ID: 34395032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From Spheroids to Organoids: The Next Generation of Model Systems of Human Cardiac Regeneration in a Dish.
    Scalise M; Marino F; Salerno L; Cianflone E; Molinaro C; Salerno N; De Angelis A; Viglietto G; Urbanek K; Torella D
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy.
    Qu J; Kalyani FS; Liu L; Cheng T; Chen L
    Cancer Commun (Lond); 2021 Dec; 41(12):1331-1353. PubMed ID: 34713636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Challenges Associated with the Use of Human Induced Pluripotent Stem Cell-Derived Organoids in Regenerative Medicine.
    Lee H; Son MY
    Int J Stem Cells; 2021 Feb; 14(1):9-20. PubMed ID: 33632980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Application of Intestinal Organoids in Intestinal Diseases.
    Liu W; Wang Q; Bai Y; Xiao H; Li Z; Wang Y; Wang Q; Yang J; Sun H
    Stem Cell Rev Rep; 2024 Jan; 20(1):124-137. PubMed ID: 37938407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancement of Organoid Technology in Regenerative Medicine.
    Arjmand B; Rabbani Z; Soveyzi F; Tayanloo-Beik A; Rezaei-Tavirani M; Biglar M; Adibi H; Larijani B
    Regen Eng Transl Med; 2023; 9(1):83-96. PubMed ID: 35968268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem Cells and Organoid Technology in Precision Medicine in Inflammation: Are We There Yet?
    Tran F; Klein C; Arlt A; Imm S; Knappe E; Simmons A; Rosenstiel P; Seibler P
    Front Immunol; 2020; 11():573562. PubMed ID: 33408713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal Stem Cells to Advance Drug Development, Precision, and Regenerative Medicine: A Paradigm Shift in Translational Research.
    Mochel JP; Jergens AE; Kingsbury D; Kim HJ; Martín MG; Allenspach K
    AAPS J; 2017 Dec; 20(1):17. PubMed ID: 29234895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal enteroids/organoids: A novel platform for drug discovery in inflammatory bowel diseases.
    Yoo JH; Donowitz M
    World J Gastroenterol; 2019 Aug; 25(30):4125-4147. PubMed ID: 31435168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell-derived organoids and their application for medical research and patient treatment.
    Bartfeld S; Clevers H
    J Mol Med (Berl); 2017 Jul; 95(7):729-738. PubMed ID: 28391362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal organoids in infants and children.
    Chusilp S; Li B; Lee D; Lee C; Vejchapipat P; Pierro A
    Pediatr Surg Int; 2020 Jan; 36(1):1-10. PubMed ID: 31555860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.